Home LiteratureArticle Details
PMID: 1980971 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interleukin-1 decreases the number of Ia+ epidermal dendritic cells but increases their expression of Ia antigen.

Acta dermato-venereologica ·Vol. 70 ·No. 5 ·1990-00-00 ·Pages 391-4

Lundqvist EN, Bäck O

Abstract

It is generally accepted that ETAF/IL-1 is produced in epidermis by both keratinocytes and Langerhans' cells. We have studied the density and morphology of Ia+ epidermal dendritic cells in mice after systemic or intracutaneous injection of recombinant IL-1 beta. We found that rIL-1 beta decreased the density of Ia+ dendritic cells in the time period 2-7 days after rIL-1 beta administration. However, the remaining dendritic cells were enlarged and more arborized with increased expression of Ia antigen 1-4 days after injection of rIL-1 beta. The implication of the results is that ETAF/IL-1 modulates the function of Langerhans' cells through autocrine and paracrine regulation.

MeSH Terms
Animals Cell Count Dendritic Cells/drug effects,immunology Dose-Response Relationship, Drug Epidermal Cells Epidermis/drug effects,immunology Fluorescent Antibody Technique Histocompatibility Antigens Class II/analysis Interleukin-1/administration & dosage,pharmacology Langerhans Cells/drug effects,immunology Male Mice Mice, Inbred C3H
Chemicals
Histocompatibility Antigens Class II Interleukin-1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lundqvist E N
Department of Dermatology, University Hospital, Umeå, Sweden.
Bäck O
Article Info
Journal
Acta dermato-venereologica
Abbr.
Acta Derm Venereol
ISSN
0001-5555
Published
1990-00-00
Pages
391-4
Language
English
Region
Sweden
NLM ID
0370310
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com